| Product Code: ETC9966699 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Industry Life Cycle |
3.4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Porter's Five Forces |
3.5 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.8 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders such as anxiety, epilepsy, and insomnia, for which GABA receptor agonists are prescribed. |
4.2.2 Growing awareness and acceptance of alternative treatments like GABA receptor agonists in the United States. |
4.2.3 Rising demand for natural supplements and products promoting relaxation and stress relief. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for new GABA receptor agonist drugs in the US market. |
4.3.2 Side effects and potential risks associated with long-term use of GABA receptor agonists. |
4.3.3 Competition from other pharmaceuticals and alternative therapies for neurological disorders. |
5 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends |
6 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Types |
6.1 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Insomnia, 2021- 2031F |
6.1.4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.5 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Spasticity, 2021- 2031F |
6.1.6 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Anxiety, 2021- 2031F |
6.1.7 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Zolpidem, 2021- 2031F |
6.2.3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Topiramate, 2021- 2031F |
6.2.4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.2.5 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Therapeutics |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Bamaluzole, 2021- 2031F |
6.3.3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Phenibut, 2021- 2031F |
6.3.4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.3.5 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Gaboxadol, 2021- 2031F |
6.4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Intrathecal, 2021- 2031F |
6.4.5 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Import-Export Trade Statistics |
7.1 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Export to Major Countries |
7.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Imports from Major Countries |
8 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on GABA receptor agonists in the United States. |
8.2 Patient satisfaction scores and feedback related to the efficacy and safety of GABA receptor agonists. |
8.3 Adoption rate of GABA receptor agonists by healthcare practitioners in the US for treating neurological conditions. |
9 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Opportunity Assessment |
9.1 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.4 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Competitive Landscape |
10.1 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |